| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thymosin | 10 | 2010 | 47 | 2.180 |
Why?
|
| Neovascularization, Pathologic | 20 | 2015 | 2640 | 1.140 |
Why?
|
| Neoplasm Metastasis | 29 | 2015 | 4902 | 1.130 |
Why?
|
| Cell Movement | 35 | 2014 | 5206 | 0.990 |
Why?
|
| Collagen | 12 | 2014 | 2636 | 0.780 |
Why?
|
| Prostatic Neoplasms | 25 | 2022 | 11345 | 0.780 |
Why?
|
| Proteins | 15 | 2019 | 6029 | 0.760 |
Why?
|
| Chemotaxis | 11 | 1999 | 598 | 0.660 |
Why?
|
| Repressor Proteins | 5 | 2020 | 2981 | 0.640 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2016 | 60 | 0.530 |
Why?
|
| Neoplasms | 23 | 2015 | 22072 | 0.520 |
Why?
|
| Cell Adhesion | 17 | 2015 | 3094 | 0.510 |
Why?
|
| Carrier Proteins | 8 | 2022 | 4938 | 0.480 |
Why?
|
| Lymphangiogenesis | 1 | 2015 | 172 | 0.450 |
Why?
|
| Endothelium | 25 | 2012 | 764 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2013 | 8515 | 0.450 |
Why?
|
| Tumor Cells, Cultured | 22 | 2017 | 6131 | 0.420 |
Why?
|
| Neovascularization, Physiologic | 5 | 2012 | 1336 | 0.420 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2015 | 2049 | 0.420 |
Why?
|
| Paclitaxel | 2 | 2011 | 1736 | 0.420 |
Why?
|
| Growth Substances | 14 | 1998 | 768 | 0.420 |
Why?
|
| Platelet-Derived Growth Factor | 12 | 2001 | 617 | 0.400 |
Why?
|
| Cell Line, Tumor | 18 | 2023 | 16939 | 0.400 |
Why?
|
| Lymphatic Metastasis | 4 | 2015 | 2943 | 0.400 |
Why?
|
| Mast Cells | 9 | 1995 | 1390 | 0.390 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2010 | 21 | 0.370 |
Why?
|
| Polyamines | 1 | 2011 | 133 | 0.370 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2526 | 0.360 |
Why?
|
| Genes, APC | 1 | 2011 | 145 | 0.360 |
Why?
|
| Capillaries | 14 | 1995 | 744 | 0.360 |
Why?
|
| Cystatin B | 1 | 2009 | 12 | 0.330 |
Why?
|
| Enzyme Assays | 1 | 2010 | 107 | 0.330 |
Why?
|
| Protein Isoforms | 3 | 2009 | 1697 | 0.320 |
Why?
|
| Animals | 99 | 2020 | 167963 | 0.320 |
Why?
|
| Ornithine Decarboxylase | 2 | 2019 | 64 | 0.310 |
Why?
|
| Molecular Probes | 1 | 2010 | 313 | 0.310 |
Why?
|
| Spermine | 2 | 1999 | 69 | 0.300 |
Why?
|
| Endothelial Cells | 3 | 2015 | 3539 | 0.300 |
Why?
|
| Endothelium, Vascular | 11 | 2015 | 4433 | 0.290 |
Why?
|
| Amino Acid Sequence | 17 | 2019 | 13451 | 0.290 |
Why?
|
| Peptide Hydrolases | 2 | 2010 | 623 | 0.290 |
Why?
|
| Centrioles | 1 | 2007 | 79 | 0.290 |
Why?
|
| Mice, Nude | 8 | 2018 | 3607 | 0.280 |
Why?
|
| Molecular Sequence Data | 17 | 2010 | 17624 | 0.280 |
Why?
|
| Ubiquitin | 3 | 2007 | 838 | 0.270 |
Why?
|
| MicroRNAs | 2 | 2013 | 3790 | 0.270 |
Why?
|
| Lung Neoplasms | 14 | 2015 | 13262 | 0.270 |
Why?
|
| Gold | 1 | 2010 | 484 | 0.270 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2011 | 5253 | 0.260 |
Why?
|
| Centrosome | 1 | 2007 | 207 | 0.260 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 399 | 0.260 |
Why?
|
| Cell Division | 16 | 2004 | 4463 | 0.260 |
Why?
|
| Cell Adhesion Molecules | 5 | 2013 | 1602 | 0.250 |
Why?
|
| Nanoparticles | 4 | 2020 | 1943 | 0.250 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 608 | 0.250 |
Why?
|
| Oligopeptides | 8 | 1998 | 1187 | 0.250 |
Why?
|
| Rats | 23 | 2007 | 23711 | 0.250 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2007 | 1313 | 0.250 |
Why?
|
| Mice | 49 | 2020 | 81208 | 0.240 |
Why?
|
| Signal Transduction | 12 | 2018 | 23376 | 0.230 |
Why?
|
| Adenocarcinoma | 5 | 2010 | 6315 | 0.230 |
Why?
|
| Extracellular Matrix | 9 | 2000 | 1726 | 0.230 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2009 | 800 | 0.230 |
Why?
|
| Apoptosis | 5 | 2020 | 9501 | 0.220 |
Why?
|
| Hematopoietic Cell Growth Factors | 2 | 1995 | 98 | 0.220 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 3726 | 0.220 |
Why?
|
| Fibronectins | 11 | 2000 | 722 | 0.220 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 257 | 0.220 |
Why?
|
| Angiogenesis Inducing Agents | 6 | 1992 | 278 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6853 | 0.210 |
Why?
|
| Neoplasm Proteins | 8 | 2007 | 3610 | 0.210 |
Why?
|
| Proteomics | 5 | 2020 | 3817 | 0.210 |
Why?
|
| Endothelial Growth Factors | 4 | 1999 | 673 | 0.200 |
Why?
|
| Cyclin D1 | 1 | 2004 | 451 | 0.200 |
Why?
|
| Laminin | 8 | 2014 | 405 | 0.200 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2009 | 2276 | 0.200 |
Why?
|
| RNA, Messenger | 11 | 2020 | 12766 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2010 | 9276 | 0.190 |
Why?
|
| Chemotactic Factors | 3 | 1992 | 196 | 0.190 |
Why?
|
| Gene Silencing | 3 | 2014 | 1513 | 0.190 |
Why?
|
| RNA Editing | 1 | 2022 | 151 | 0.190 |
Why?
|
| Umbilical Veins | 4 | 2010 | 426 | 0.190 |
Why?
|
| Humans | 103 | 2023 | 760621 | 0.190 |
Why?
|
| Medical Oncology | 2 | 2014 | 2313 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2020 | 2864 | 0.180 |
Why?
|
| Cells, Cultured | 26 | 2010 | 18957 | 0.180 |
Why?
|
| Allantois | 3 | 2003 | 33 | 0.180 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2000 | 56 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2015 | 5251 | 0.170 |
Why?
|
| Thrombin | 7 | 1979 | 593 | 0.170 |
Why?
|
| Neoplasm Transplantation | 4 | 2011 | 2014 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 5 | 2010 | 3800 | 0.170 |
Why?
|
| Chorion | 3 | 2003 | 114 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2002 | 544 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2015 | 730 | 0.170 |
Why?
|
| Mass Spectrometry | 5 | 2007 | 2192 | 0.170 |
Why?
|
| Lymphokines | 3 | 1999 | 927 | 0.170 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 1204 | 0.170 |
Why?
|
| Receptors, Cell Surface | 6 | 1993 | 2825 | 0.170 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2000 | 187 | 0.160 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2011 | 590 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2002 | 3735 | 0.160 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 3442 | 0.160 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2000 | 242 | 0.160 |
Why?
|
| Base Sequence | 8 | 2011 | 12446 | 0.160 |
Why?
|
| Nucleoside-Diphosphate Kinase | 2 | 1999 | 17 | 0.150 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2000 | 277 | 0.150 |
Why?
|
| Actins | 3 | 2022 | 2049 | 0.150 |
Why?
|
| Disease Progression | 5 | 2013 | 13502 | 0.150 |
Why?
|
| Up-Regulation | 5 | 2011 | 4122 | 0.150 |
Why?
|
| Cattle | 19 | 2007 | 3847 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 1999 | 1485 | 0.150 |
Why?
|
| Transfection | 8 | 2018 | 5781 | 0.150 |
Why?
|
| Cadherins | 2 | 2013 | 898 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3804 | 0.150 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 3 | 1995 | 178 | 0.150 |
Why?
|
| beta Catenin | 1 | 2023 | 1043 | 0.150 |
Why?
|
| Fibroblasts | 8 | 2006 | 4090 | 0.150 |
Why?
|
| Elastin | 5 | 1990 | 301 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2014 | 3426 | 0.140 |
Why?
|
| Growth Inhibitors | 2 | 1995 | 378 | 0.140 |
Why?
|
| Genes | 1 | 2000 | 1845 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 2 | 1999 | 200 | 0.140 |
Why?
|
| Sequence Alignment | 3 | 2009 | 2176 | 0.140 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 419 | 0.140 |
Why?
|
| Carbamates | 1 | 2017 | 192 | 0.130 |
Why?
|
| RNA Interference | 3 | 2010 | 2846 | 0.130 |
Why?
|
| Carcinoma | 4 | 1996 | 2331 | 0.130 |
Why?
|
| 3T3 Cells | 6 | 2001 | 1085 | 0.130 |
Why?
|
| Protein Binding | 8 | 2021 | 9335 | 0.130 |
Why?
|
| Peptides | 8 | 2010 | 4354 | 0.130 |
Why?
|
| Type C Phospholipases | 3 | 2005 | 287 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 4 | 2014 | 3618 | 0.120 |
Why?
|
| Protein Biosynthesis | 3 | 1999 | 2105 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 4024 | 0.120 |
Why?
|
| Plasminogen | 3 | 2001 | 146 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 1989 | 663 | 0.120 |
Why?
|
| Heat-Shock Proteins | 2 | 1997 | 795 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 1994 | 17 | 0.120 |
Why?
|
| Blood Vessels | 6 | 2004 | 1112 | 0.120 |
Why?
|
| Blotting, Western | 6 | 2011 | 5039 | 0.120 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1994 | 74 | 0.120 |
Why?
|
| ras Proteins | 2 | 1999 | 1052 | 0.120 |
Why?
|
| Receptor, Insulin | 2 | 1998 | 836 | 0.110 |
Why?
|
| Glutathione Transferase | 3 | 2010 | 565 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3602 | 0.110 |
Why?
|
| Keratin-18 | 1 | 2013 | 38 | 0.110 |
Why?
|
| Isotope Labeling | 4 | 2010 | 392 | 0.110 |
Why?
|
| Male | 37 | 2022 | 359744 | 0.110 |
Why?
|
| DNA, Complementary | 3 | 2001 | 1991 | 0.110 |
Why?
|
| Membrane Proteins | 7 | 2003 | 7850 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 1652 | 0.110 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 4169 | 0.110 |
Why?
|
| Organ Specificity | 5 | 1996 | 1955 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 755 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 3 | 2010 | 1705 | 0.110 |
Why?
|
| History, 20th Century | 2 | 2014 | 2773 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1699 | 0.110 |
Why?
|
| Epidermal Growth Factor | 4 | 1989 | 695 | 0.110 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 1046 | 0.110 |
Why?
|
| Neoplasms, Experimental | 7 | 2017 | 1229 | 0.110 |
Why?
|
| Vimentin | 1 | 2013 | 255 | 0.110 |
Why?
|
| Chick Embryo | 8 | 2003 | 981 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-sis | 4 | 2000 | 256 | 0.100 |
Why?
|
| Tissue Extracts | 3 | 1995 | 140 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1115 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 1997 | 911 | 0.100 |
Why?
|
| Phospholipase C gamma | 2 | 2005 | 130 | 0.100 |
Why?
|
| Benzimidazoles | 1 | 2017 | 858 | 0.100 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 3084 | 0.100 |
Why?
|
| Antibodies | 2 | 2007 | 2421 | 0.100 |
Why?
|
| DNA Primers | 3 | 2011 | 2819 | 0.100 |
Why?
|
| Cell Line | 15 | 2002 | 15620 | 0.100 |
Why?
|
| Interleukin-3 | 2 | 1992 | 425 | 0.100 |
Why?
|
| Recombinant Proteins | 7 | 2005 | 6538 | 0.100 |
Why?
|
| Catenins | 1 | 2011 | 41 | 0.100 |
Why?
|
| Aqueous Humor | 2 | 1983 | 153 | 0.100 |
Why?
|
| Culture Media | 8 | 1989 | 900 | 0.100 |
Why?
|
| Integrins | 2 | 1993 | 839 | 0.100 |
Why?
|
| Angiostatins | 3 | 2001 | 64 | 0.100 |
Why?
|
| Water | 1 | 2017 | 1407 | 0.090 |
Why?
|
| Transplantation, Heterologous | 3 | 2013 | 2379 | 0.090 |
Why?
|
| Transferrin | 1 | 1992 | 284 | 0.090 |
Why?
|
| Lysophospholipids | 3 | 2000 | 339 | 0.090 |
Why?
|
| Hemangioma | 2 | 1995 | 728 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 459 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 4490 | 0.090 |
Why?
|
| Prostate | 2 | 1996 | 1793 | 0.090 |
Why?
|
| Proton-Translocating ATPases | 1 | 2010 | 113 | 0.090 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2012 | 268 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 3 | 2005 | 2529 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2012 | 3484 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 3 | 2001 | 475 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1998 | 2418 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2015 | 709 | 0.080 |
Why?
|
| Galectin 3 | 1 | 2011 | 240 | 0.080 |
Why?
|
| Protein Kinases | 1 | 1997 | 1612 | 0.080 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 1189 | 0.080 |
Why?
|
| Binding Sites | 4 | 2021 | 6048 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2020 | 10446 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 2012 | 1167 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 2471 | 0.080 |
Why?
|
| Protein Kinase C | 2 | 1993 | 1199 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1246 | 0.080 |
Why?
|
| Polymers | 2 | 2014 | 1621 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3106 | 0.080 |
Why?
|
| Breast Neoplasms | 6 | 2007 | 21025 | 0.080 |
Why?
|
| Cell Communication | 1 | 2015 | 1653 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 551 | 0.080 |
Why?
|
| Trypsin | 2 | 2007 | 496 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 2753 | 0.080 |
Why?
|
| Microscopy, Electron | 2 | 2010 | 2558 | 0.070 |
Why?
|
| Immune Evasion | 2 | 2021 | 362 | 0.070 |
Why?
|
| Wound Healing | 6 | 2010 | 2788 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5791 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2012 | 1928 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2014 | 1575 | 0.070 |
Why?
|
| Trypsinogen | 1 | 2007 | 84 | 0.070 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 13630 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 401 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 1689 | 0.070 |
Why?
|
| Lipids | 2 | 2018 | 3336 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2021 | 5075 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 1999 | 748 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4264 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1649 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 1693 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2018 | 2448 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 1484 | 0.070 |
Why?
|
| Kinetics | 7 | 2002 | 6377 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 626 | 0.060 |
Why?
|
| Bone Marrow | 3 | 1992 | 2912 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2015 | 3380 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2005 | 234 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1998 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 2021 | 361 | 0.060 |
Why?
|
| Melanoma | 7 | 2004 | 5697 | 0.060 |
Why?
|
| Mutation | 6 | 2021 | 29932 | 0.060 |
Why?
|
| Prognosis | 5 | 2010 | 29658 | 0.060 |
Why?
|
| Cell Membrane | 4 | 2010 | 3682 | 0.060 |
Why?
|
| Lipoproteins, LDL | 2 | 1985 | 641 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2005 | 365 | 0.060 |
Why?
|
| Recurrence | 2 | 2009 | 8482 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2000 | 6551 | 0.060 |
Why?
|
| Blood | 2 | 1977 | 586 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 1998 | 749 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 1262 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 670 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 2 | 2010 | 2882 | 0.060 |
Why?
|
| Talin | 1 | 2004 | 46 | 0.060 |
Why?
|
| Sarcoma, Experimental | 2 | 1983 | 117 | 0.060 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 1995 | 93 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 315 | 0.060 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11152 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1972 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4878 | 0.060 |
Why?
|
| Mitogens | 3 | 1978 | 230 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3215 | 0.050 |
Why?
|
| Macrophage-Activating Factors | 1 | 2003 | 21 | 0.050 |
Why?
|
| Thioredoxins | 1 | 2004 | 201 | 0.050 |
Why?
|
| Actinin | 1 | 2004 | 163 | 0.050 |
Why?
|
| Stem Cell Factor | 2 | 1995 | 196 | 0.050 |
Why?
|
| Endopeptidases | 2 | 1998 | 772 | 0.050 |
Why?
|
| Furin | 1 | 2003 | 46 | 0.050 |
Why?
|
| Osteopontin | 1 | 2005 | 302 | 0.050 |
Why?
|
| Molecular Imaging | 1 | 2010 | 818 | 0.050 |
Why?
|
| Subtilisins | 1 | 2003 | 82 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2021 | 1885 | 0.050 |
Why?
|
| Blood Platelets | 4 | 1982 | 2520 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 1998 | 938 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2005 | 279 | 0.050 |
Why?
|
| Aorta | 5 | 1985 | 2039 | 0.050 |
Why?
|
| Glycoproteins | 3 | 1979 | 2208 | 0.050 |
Why?
|
| Peptide Fragments | 3 | 2001 | 5125 | 0.050 |
Why?
|
| Iliac Artery | 2 | 1987 | 344 | 0.050 |
Why?
|
| Platelet Adhesiveness | 2 | 1982 | 154 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 1229 | 0.050 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2003 | 131 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1167 | 0.050 |
Why?
|
| Tyrosine | 3 | 1998 | 1438 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 548 | 0.050 |
Why?
|
| Amino Acids | 2 | 2004 | 1714 | 0.050 |
Why?
|
| Molecular Weight | 4 | 1992 | 2186 | 0.050 |
Why?
|
| Genes, BRCA2 | 1 | 2005 | 603 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3584 | 0.050 |
Why?
|
| Eye Neoplasms | 1 | 1983 | 306 | 0.050 |
Why?
|
| Heparin | 3 | 2003 | 1652 | 0.050 |
Why?
|
| Cell Extracts | 2 | 1997 | 135 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 2 | 2013 | 5351 | 0.050 |
Why?
|
| Receptors, Very Late Antigen | 2 | 1991 | 74 | 0.050 |
Why?
|
| CHO Cells | 2 | 1994 | 1389 | 0.050 |
Why?
|
| Genes, BRCA1 | 1 | 2005 | 765 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2001 | 361 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 666 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2002 | 1055 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 231 | 0.050 |
Why?
|
| Clone Cells | 3 | 1983 | 1660 | 0.050 |
Why?
|
| Monocytes | 2 | 1987 | 2575 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2003 | 2627 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 2 | 1997 | 34 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2002 | 472 | 0.040 |
Why?
|
| Platelet Factor 4 | 2 | 1996 | 129 | 0.040 |
Why?
|
| Retinal Vessels | 2 | 1983 | 836 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 22023 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 818 | 0.040 |
Why?
|
| Cell Count | 3 | 1996 | 1835 | 0.040 |
Why?
|
| Cricetinae | 2 | 1994 | 2427 | 0.040 |
Why?
|
| Ovary | 1 | 1984 | 958 | 0.040 |
Why?
|
| DNA | 6 | 2000 | 7233 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2010 | 22053 | 0.040 |
Why?
|
| Time | 1 | 2021 | 545 | 0.040 |
Why?
|
| Female | 14 | 2020 | 391270 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2020 | 193 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3775 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2021 | 728 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2696 | 0.040 |
Why?
|
| Insulin | 1 | 1994 | 6597 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 1999 | 316 | 0.040 |
Why?
|
| Luciferases | 1 | 2000 | 716 | 0.040 |
Why?
|
| Factor VIII | 4 | 1983 | 349 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2002 | 534 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2020 | 674 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2006 | 11903 | 0.040 |
Why?
|
| Proteome | 2 | 2010 | 1855 | 0.040 |
Why?
|
| Culture Media, Conditioned | 2 | 2003 | 522 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2000 | 4713 | 0.040 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 2 | 1999 | 21 | 0.040 |
Why?
|
| Teratoma | 2 | 1978 | 403 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2002 | 1084 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 2 | 1998 | 869 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1999 | 12103 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2019 | 320 | 0.040 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1999 | 361 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 978 | 0.040 |
Why?
|
| Survival Rate | 2 | 2010 | 12808 | 0.040 |
Why?
|
| Endometrial Neoplasms | 1 | 2007 | 1357 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 201 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1989 | 221 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 639 | 0.040 |
Why?
|
| Methods | 3 | 1985 | 1074 | 0.040 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1997 | 49 | 0.040 |
Why?
|
| Coliphages | 2 | 1974 | 120 | 0.040 |
Why?
|
| Endostatins | 1 | 1998 | 168 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2010 | 3446 | 0.040 |
Why?
|
| Pituitary Hormones | 1 | 1978 | 182 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 1989 | 2532 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2014 | 801 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 1529 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 461 | 0.030 |
Why?
|
| Mitochondria | 1 | 2010 | 3600 | 0.030 |
Why?
|
| Mouth Diseases | 1 | 1979 | 238 | 0.030 |
Why?
|
| RNA, Antisense | 1 | 1996 | 136 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1993 | 1142 | 0.030 |
Why?
|
| Interferons | 1 | 1980 | 705 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2005 | 1956 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 518 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 489 | 0.030 |
Why?
|
| Phosphorylation | 3 | 1998 | 8313 | 0.030 |
Why?
|
| Epoprostenol | 3 | 1982 | 248 | 0.030 |
Why?
|
| Phosphotransferases | 2 | 1974 | 303 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 1979 | 426 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 1088 | 0.030 |
Why?
|
| Putrescine | 1 | 1995 | 42 | 0.030 |
Why?
|
| Receptors, Immunologic | 2 | 1993 | 1411 | 0.030 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 1995 | 34 | 0.030 |
Why?
|
| ras-GRF1 | 1 | 1995 | 26 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 1135 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 1978 | 2828 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 1996 | 152 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 68 | 0.030 |
Why?
|
| Culture Techniques | 4 | 1982 | 530 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2648 | 0.030 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 1999 | 487 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 6216 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1690 | 0.030 |
Why?
|
| Blastocyst | 1 | 1978 | 433 | 0.030 |
Why?
|
| Microsomes | 1 | 1995 | 252 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 203 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 1996 | 176 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1995 | 81 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1997 | 642 | 0.030 |
Why?
|
| Guanidines | 1 | 1995 | 193 | 0.030 |
Why?
|
| Oncogene Protein gp140(v-fms) | 1 | 1994 | 2 | 0.030 |
Why?
|
| Oncogene Proteins v-sis | 1 | 1994 | 2 | 0.030 |
Why?
|
| Exons | 1 | 2000 | 2388 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 1994 | 5 | 0.030 |
Why?
|
| Epitopes | 1 | 2021 | 2503 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1997 | 397 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2262 | 0.030 |
Why?
|
| Contact Inhibition | 3 | 1978 | 46 | 0.030 |
Why?
|
| Pancreatic Elastase | 2 | 1989 | 128 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2554 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1995 | 814 | 0.030 |
Why?
|
| Muramidase | 1 | 1974 | 169 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2014 | 2025 | 0.030 |
Why?
|
| Hormones | 1 | 1998 | 867 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 58995 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1996 | 1155 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 1995 | 367 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11071 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 1895 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 951 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2014 | 326 | 0.030 |
Why?
|
| Carcinoma, Lobular | 1 | 1997 | 489 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1543 | 0.030 |
Why?
|
| Mesoderm | 2 | 2012 | 672 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2002 | 9530 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 1982 | 1268 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1997 | 752 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 1993 | 323 | 0.030 |
Why?
|
| Podophyllotoxin | 1 | 2012 | 21 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2021 | 6218 | 0.030 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2012 | 35 | 0.030 |
Why?
|
| Viral Load | 1 | 2021 | 3322 | 0.030 |
Why?
|
| Receptors, Cytoadhesin | 1 | 1992 | 8 | 0.030 |
Why?
|
| Antigens | 3 | 1983 | 1447 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2000 | 1664 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 1997 | 796 | 0.020 |
Why?
|
| Cytokines | 2 | 1998 | 7343 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 1994 | 557 | 0.020 |
Why?
|
| Embryoid Bodies | 1 | 2012 | 65 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2058 | 0.020 |
Why?
|
| Research Design | 2 | 2003 | 6180 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1994 | 436 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1995 | 568 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 1994 | 535 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 1996 | 918 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1998 | 2608 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1933 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 2895 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 10827 | 0.020 |
Why?
|
| Biological Factors | 1 | 1992 | 157 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1999 | 1613 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5434 | 0.020 |
Why?
|
| Biological Transport | 1 | 2015 | 2086 | 0.020 |
Why?
|
| United States | 2 | 2021 | 72461 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 1992 | 291 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1997 | 1096 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 566 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2001 | 2440 | 0.020 |
Why?
|
| Tropoelastin | 1 | 1989 | 28 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2012 | 11481 | 0.020 |
Why?
|
| Connective Tissue Cells | 1 | 1989 | 50 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2000 | 7593 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14660 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3143 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 75 | 0.020 |
Why?
|
| Models, Biological | 4 | 2012 | 9467 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 380 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 5785 | 0.020 |
Why?
|
| Mass Screening | 1 | 2005 | 5423 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2725 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 616 | 0.020 |
Why?
|
| Spleen | 2 | 1989 | 2298 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 1990 | 279 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1989 | 218 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2394 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15289 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2007 | 8986 | 0.020 |
Why?
|
| Epithelium | 3 | 1983 | 1605 | 0.020 |
Why?
|
| Staurosporine | 1 | 1989 | 242 | 0.020 |
Why?
|
| Public Health | 1 | 2021 | 2653 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9411 | 0.020 |
Why?
|
| Alkaloids | 1 | 1989 | 194 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1991 | 359 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 621 | 0.020 |
Why?
|
| Venules | 1 | 1988 | 164 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3105 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5797 | 0.020 |
Why?
|
| Cell Separation | 2 | 2001 | 1720 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1992 | 829 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 1995 | 2907 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1988 | 420 | 0.020 |
Why?
|
| Aged | 4 | 2010 | 169152 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4550 | 0.020 |
Why?
|
| Rabbits | 3 | 1988 | 4773 | 0.020 |
Why?
|
| Tuftsin | 1 | 1985 | 4 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1985 | 169 | 0.020 |
Why?
|
| Plant Lectins | 1 | 1985 | 103 | 0.020 |
Why?
|
| Soybean Proteins | 1 | 1985 | 55 | 0.020 |
Why?
|
| Alprostadil | 1 | 1985 | 86 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 789 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 2094 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1617 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1988 | 685 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 6068 | 0.020 |
Why?
|
| Middle Aged | 4 | 2010 | 220352 | 0.020 |
Why?
|
| Blindness | 2 | 1996 | 582 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 1985 | 115 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2006 | 459 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2006 | 439 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2008 | 412 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1992 | 716 | 0.020 |
Why?
|
| Prostaglandins | 2 | 1988 | 398 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1974 | 4219 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 1984 | 81 | 0.010 |
Why?
|
| Adhesiveness | 1 | 1984 | 52 | 0.010 |
Why?
|
| Sarcoma 180 | 1 | 1983 | 6 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9185 | 0.010 |
Why?
|
| Histamine | 1 | 1985 | 498 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1985 | 190 | 0.010 |
Why?
|
| Ovarian Follicle | 1 | 1984 | 244 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 74359 | 0.010 |
Why?
|
| Lung | 3 | 1986 | 9994 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1987 | 1064 | 0.010 |
Why?
|
| Neuraminidase | 1 | 2003 | 200 | 0.010 |
Why?
|
| Arginine | 1 | 2006 | 934 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2010 | 1804 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 1984 | 488 | 0.010 |
Why?
|
| Paxillin | 1 | 2001 | 86 | 0.010 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1985 | 662 | 0.010 |
Why?
|
| Acetylation | 1 | 1984 | 1062 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 1982 | 95 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 575 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1998 | 8056 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1989 | 2414 | 0.010 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2001 | 133 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2924 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1983 | 317 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1983 | 296 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1992 | 3112 | 0.010 |
Why?
|
| Eosinophils | 1 | 1985 | 944 | 0.010 |
Why?
|
| Androgens | 1 | 2008 | 1291 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 5799 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 20080 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2002 | 658 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1980 | 194 | 0.010 |
Why?
|
| Iris | 1 | 1981 | 231 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1129 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2003 | 554 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2001 | 568 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Education | 1 | 2002 | 534 | 0.010 |
Why?
|
| Incidence | 1 | 1998 | 21392 | 0.010 |
Why?
|
| Acantholysis | 1 | 1979 | 11 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1982 | 397 | 0.010 |
Why?
|
| Research | 1 | 2008 | 1974 | 0.010 |
Why?
|
| Retroviridae | 1 | 2001 | 850 | 0.010 |
Why?
|
| Macrophages | 2 | 2003 | 5745 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18137 | 0.010 |
Why?
|
| Adult | 4 | 2010 | 219994 | 0.010 |
Why?
|
| Membrane Fluidity | 1 | 1978 | 68 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 1982 | 673 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 326 | 0.010 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 1979 | 61 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1981 | 573 | 0.010 |
Why?
|
| Lichen Planus | 1 | 1979 | 71 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1998 | 119 | 0.010 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 1979 | 85 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1977 | 80 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1983 | 651 | 0.010 |
Why?
|
| Retinal Detachment | 1 | 1982 | 427 | 0.010 |
Why?
|
| Pemphigus | 1 | 1979 | 116 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1998 | 186 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1985 | 1913 | 0.010 |
Why?
|
| Birds | 1 | 1978 | 168 | 0.010 |
Why?
|
| Endoderm | 1 | 1978 | 160 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1983 | 1166 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1977 | 76 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 1997 | 162 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 449 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1979 | 554 | 0.010 |
Why?
|
| Diploidy | 1 | 1976 | 132 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2003 | 1557 | 0.010 |
Why?
|
| Specimen Handling | 1 | 1981 | 707 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1979 | 416 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2138 | 0.010 |
Why?
|
| Thermolysin | 1 | 1976 | 14 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1978 | 281 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1992 | 3763 | 0.010 |
Why?
|
| Bromelains | 1 | 1976 | 8 | 0.010 |
Why?
|
| Cornea | 2 | 1988 | 1326 | 0.010 |
Why?
|
| Papain | 1 | 1976 | 65 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1988 | 3301 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1997 | 331 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1343 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 1999 | 558 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1999 | 666 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1978 | 618 | 0.010 |
Why?
|
| Mitosis | 2 | 1980 | 1191 | 0.010 |
Why?
|
| RNA, Bacterial | 2 | 1974 | 385 | 0.010 |
Why?
|
| Species Specificity | 1 | 1979 | 2418 | 0.010 |
Why?
|
| Pimelic Acids | 1 | 1974 | 2 | 0.010 |
Why?
|
| Deoxyribonucleotides | 1 | 1974 | 43 | 0.010 |
Why?
|
| Thymine Nucleotides | 1 | 1974 | 59 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1976 | 378 | 0.010 |
Why?
|
| Swine | 1 | 1984 | 5899 | 0.010 |
Why?
|
| Flavonoids | 1 | 1997 | 445 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 2651 | 0.010 |
Why?
|
| Breast Diseases | 1 | 1997 | 443 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1974 | 299 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1980 | 1535 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1984 | 1403 | 0.010 |
Why?
|
| Cartilage | 1 | 1978 | 806 | 0.010 |
Why?
|
| Tritium | 1 | 1974 | 707 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1976 | 562 | 0.010 |
Why?
|
| Serotonin | 1 | 1978 | 1040 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1977 | 1754 | 0.010 |
Why?
|
| Embryonic Development | 1 | 1978 | 716 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 557 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1974 | 358 | 0.010 |
Why?
|
| Diabetes Mellitus | 2 | 1999 | 5889 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1978 | 1674 | 0.010 |
Why?
|
| Inflammation | 1 | 1992 | 10756 | 0.010 |
Why?
|
| Software | 1 | 2006 | 4419 | 0.010 |
Why?
|
| Leukocytes | 1 | 1980 | 2026 | 0.010 |
Why?
|
| Liver | 2 | 1985 | 7509 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1978 | 1097 | 0.010 |
Why?
|
| Ethanol | 1 | 1997 | 1323 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 1990 | 25 | 0.010 |
Why?
|
| Receptors, Laminin | 1 | 1990 | 26 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 1990 | 37 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1990 | 168 | 0.010 |
Why?
|
| Temperature | 1 | 1977 | 2221 | 0.010 |
Why?
|
| Viral Proteins | 2 | 1974 | 1802 | 0.010 |
Why?
|
| Gestational Age | 1 | 1978 | 3565 | 0.010 |
Why?
|
| Contrast Media | 1 | 2002 | 5305 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8158 | 0.000 |
Why?
|
| Breast | 1 | 1997 | 1963 | 0.000 |
Why?
|
| Kidney | 1 | 1983 | 7064 | 0.000 |
Why?
|
| Glucose | 1 | 1999 | 4351 | 0.000 |
Why?
|
| Indomethacin | 1 | 1988 | 326 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 176 | 0.000 |
Why?
|
| Antiviral Agents | 1 | 1980 | 3061 | 0.000 |
Why?
|
| Heparitin Sulfate | 1 | 1988 | 224 | 0.000 |
Why?
|
| Time Factors | 2 | 2001 | 40165 | 0.000 |
Why?
|
| Virus Replication | 1 | 1974 | 2432 | 0.000 |
Why?
|
| Yolk Sac | 1 | 1985 | 79 | 0.000 |
Why?
|
| Skin | 1 | 1979 | 4466 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1974 | 2838 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1985 | 700 | 0.000 |
Why?
|
| Lectins | 1 | 1985 | 484 | 0.000 |
Why?
|
| Ligands | 1 | 1990 | 3276 | 0.000 |
Why?
|
| Bacterial Proteins | 2 | 1974 | 3826 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1983 | 306 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1990 | 3969 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1983 | 645 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1980 | 294 | 0.000 |
Why?
|
| Indoles | 1 | 1985 | 1829 | 0.000 |
Why?
|
| Platelet Aggregation | 1 | 1980 | 805 | 0.000 |
Why?
|
| Muscle, Smooth | 1 | 1980 | 924 | 0.000 |
Why?
|
| Pregnancy | 1 | 1978 | 29749 | 0.000 |
Why?
|
| Adolescent | 2 | 1997 | 87810 | 0.000 |
Why?
|
| Coronary Disease | 1 | 1988 | 5990 | 0.000 |
Why?
|
| Chloramphenicol | 1 | 1972 | 71 | 0.000 |
Why?
|
| Genetics, Microbial | 1 | 1972 | 55 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1988 | 4319 | 0.000 |
Why?
|
| Chromatin | 1 | 1983 | 2938 | 0.000 |
Why?
|
| Rifampin | 1 | 1972 | 340 | 0.000 |
Why?
|
| Potassium | 1 | 1972 | 1313 | 0.000 |
Why?
|
| Infant | 1 | 1982 | 36060 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1982 | 42063 | 0.000 |
Why?
|
| Child | 1 | 1982 | 79806 | 0.000 |
Why?
|